Browse by author
Lookup NU author(s): Dr Vinciane Saint-CriqORCiD, Livia Delpiano, JinHeng Lin, Dr Michael Gray
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© 2021 The Author(s)Background: The clinical response to cystic fibrosis transmembrane conductance regulator (CFTR) modulators varies between people with cystic fibrosis (CF) of the same genotype, in part through the action of solute carriers encoded by modifier genes. Here, we investigate whether phosphate transport by SLC34A2 modulates the function of F508del-CFTR after its rescue by CFTR correctors. Methods: With Fischer rat thyroid (FRT) cells heterologously expressing wild-type and F508del-CFTR and fully-differentiated CF and non-CF human airway epithelial cells, we studied SLC34A2 expression and the effects of phosphate on CFTR-mediated transepithelial ion transport. F508del-CFTR was trafficked to the plasma membrane by incubation with different CFTR correctors (alone or in combination) or by low temperature. Results: Quantitative RT-PCR demonstrated that both FRT and primary airway epithelial cells express SLC34A2 mRNA and no differences were found between cells expressing wild-type and F508del-CFTR. For both heterologously expressed and native F508del-CFTR rescued by either VX-809 or C18, the magnitude of CFTR-mediated Cl− currents was dependent on the presence of extracellular phosphate. However, this effect of phosphate was not detected with wild-type and low temperature-rescued F508del-CFTR Cl− currents. Importantly, the modulatory effect of phosphate was observed in native CF airway cells exposed to VX-445, VX-661 and VX-770 (Trikafta) and was dependent on the presence of both sodium and phosphate. Conclusions: Extracellular phosphate modulates the magnitude of CFTR-mediated Cl− currents after F508del-CFTR rescue by clinically-approved CFTR correctors. This effect likely involves electrogenic phosphate transport by SLC34A2. It might contribute to inter-individual variability in the clinical response to CFTR correctors.
Author(s): Saint-Criq V, Wang Y, Delpiano L, Lin J, Sheppard DN, Gray MA
Publication type: Article
Publication status: Published
Journal: Journal of Cystic Fibrosis
Year: 2021
Volume: 20
Issue: 5
Pages: 843-850
Print publication date: 01/09/2021
Online publication date: 18/05/2021
Acceptance date: 26/04/2021
Date deposited: 24/05/2022
ISSN (print): 1569-1993
ISSN (electronic): 1873-5010
Publisher: Elsevier B.V.
URL: https://doi.org/10.1016/j.jcf.2021.04.013
DOI: 10.1016/j.jcf.2021.04.013
Altmetrics provided by Altmetric
